| # | Drug | Count |
|---|---|---|
| 0 | CERTOLIZUMAB PEGOL | 419 |
| 1 | ADALIMUMAB | 137 |
| 2 | METHOTREXATE SODIUM | 123 |
| 3 | SECUKINUMAB | 119 |
| 4 | METHOTREXATE | 98 |
| 5 | CELECOXIB | 92 |
| 6 | ADALIMUMAB-ADAZ | 79 |
| 7 | NAPROXEN SODIUM | 75 |
| 8 | INFLIXIMAB | 72 |
| 9 | NAPROXEN | 72 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADALIMUMAB-AACF | 11 | 0.0367 |
| 1 | CERTOLIZUMAB PEGOL | 419 | 0.0036 |
| 2 | BIMEKIZUMAB | 51 | 0.0024 |
| 3 | PIROXICAM | 10 | 0.0016 |
| 4 | ADALIMUMAB-ADAZ | 79 | 0.0015 |
| 5 | FLURBIPROFEN | 2 | 0.0013 |
| 6 | ADALIMUMAB-FKJP | 58 | 0.0013 |
| 7 | COLESTIPOL HYDROCHLORIDE | 3 | 0.0012 |
| 8 | GOLIMUMAB | 14 | 0.0011 |
| 9 | ADALIMUMAB-AATY | 53 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 552 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 207 |
| 2 | Interleukin-17A Antagonist [EPC] | 125 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 98 |
| 4 | Corticosteroid [EPC] | 74 |
| 5 | Aminosalicylate [EPC] | 46 |
| 6 | Provitamin D2 Compound [EPC] | 32 |
| 7 | Interleukin-23 Antagonist [EPC] | 27 |
| 8 | Janus Kinase Inhibitor [EPC] | 27 |
| 9 | Interleukin-12 Antagonist [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17A Antagonist [EPC] | 125 | 0.0006 |
| 1 | Thyroid Hormone Synthesis Inhibitor [EPC] | 6 | 0.0006 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 552 | 0.0006 |
| 3 | Carnitine Analog [EPC] | 2 | 0.0006 |
| 4 | Gonadotropin [EPC] | 1 | 0.0005 |
| 5 | Aminosalicylate [EPC] | 46 | 0.0003 |
| 6 | Alkaloid [EPC] | 8 | 0.0003 |
| 7 | Interleukin-1 Receptor Antagonist [EPC] | 4 | 0.0002 |
| 8 | Interleukin-12 Antagonist [EPC] | 24 | 0.0002 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 98 | 0.0002 |